Abiraterone 500mgTablet
Anti-Cancer

Abiraterone 500mg

Abiraterone Acetate

Selective CYP17A1 inhibitor that blocks androgen biosynthesis in the testes, adrenal glands, and tumour tissue, suppressing testosterone to near-undetectable levels in castration-resistant prostate cancer. Co-administered with prednisone, it significantly extends overall survival in both mCRPC and metastatic castration-sensitive prostate cancer. Available in 250mg and 500mg tablets from Cipla and Glenmark as cost-effective generics to Zytiga for prostate oncology export.

Strengths

250mg / 500mg

Packing

60 tablets/bottle

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Abiraterone Acetate 250mg / 500mg
Dosage Form
Tablet
Available Strengths
250mg / 500mg
Packing
60 tablets/bottle
Route of Administration
Oral, on empty stomach (no food 2 hours before and 1 hour after)
Dosage
1000mg once daily in combination with prednisone 5mg twice daily
Indications
Metastatic castration-resistant prostate cancer (mCRPC), metastatic high-risk castration-sensitive prostate cancer
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 20-25°C, protected from moisture
Shelf Life
24 months
Side Effects
Joint pain, hypertension, edema, hypokalemia, fatigue, hot flush, diarrhea, urinary tract infection
Precautions
Must be taken on empty stomach; monitor liver function, blood pressure, and potassium; concurrent prednisone required; women who are pregnant should not handle this medication

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Sorafenib 200mgTablet

Sorafenib 200mg

Sorafenib Tosylate

Soranib (Sorafenib 200mg) is an oral anti-cancer medicine that works by blocking abnormal protein signals that cause cancer cells to multiply. It helps stop or slow the spread of cancer in hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid carcinoma. Available for global pharmaceutical export with WHO-GMP certification.

200mg
Lenalidomide 25mgCapsule

Lenalidomide 25mg

Lenalidomide

Lenalid (Lenalidomide 25mg) is an anti-cancer medicine that works by enhancing the immune system to attack cancer cells while preventing growth of new blood vessels within tumors. It is used for treatment of multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. Available in 5mg, 10mg, and 25mg capsule strengths for global pharmaceutical export.

5mg / 10mg / 25mg
Imatinib 400mgTablet

Imatinib 400mg

Imatinib Mesylate

First-in-class BCR-ABL tyrosine kinase inhibitor that transformed CML from a fatal disease into a chronically manageable condition, achieving complete cytogenetic response in over 80% of newly diagnosed chronic-phase patients. It also targets c-KIT and PDGFR, making it the standard first-line treatment for unresectable or metastatic GIST and Ph+ ALL. Cipla and Sun Pharma manufacture affordable Indian generics in both 100mg and 400mg tablet strengths exported to oncology programmes worldwide.

100mg / 400mg

Need bulk pricing for Abiraterone 500mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote